Literature DB >> 8930961

Melatonin prevents oxidative stress-induced cell death in hippocampal cells.

F Lezoualc'h1, T Skutella, M Widmann, C Behl.   

Abstract

The pineal hormone melatonin has been suggested to be a very effective antioxidant in the brain. Oxidative stress may play a role in certain neuropathological conditions and the hippocampus is an early target of neurodegeneration. Using cells of the clonal hippocampal cell line HT22 and organotypic hippocampal rat brain slice cultures, we investigated a possible protective role of melatonin against oxidative stress-induced hippocampal cell death. Glutamate alone induced oxidative apoptotic cell death in HT22 cells as detected with Hoechst staining and DNA fragmentation analysis. Preincubation with 1 mM melatonin protected HT22 cells against glutamate-induced cell death and protected organotypic hippocampal slices against H2O2-induced cell death. These findings suggest that this neurohormone may be useful in the prevention of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930961     DOI: 10.1097/00001756-199609020-00003

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

Review 2.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

3.  Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl.

Authors:  W M Behan; M McDonald; L G Darlington; T W Stone
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 4.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

5.  Melatonin fails to protect against long-term MPTP-induced dopamine depletion in mouse striatum.

Authors:  C J van der Schyf; K Castagnoli; S Palmer; L Hazelwood; N Castagnoli
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

6.  Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants.

Authors:  A Post; F Holsboer; C Behl
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

7.  Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin.

Authors:  Jeremy E Chojnacki; Kai Liu; Xing Yan; Stefano Toldo; Tyler Selden; Martin Estrada; María Isabel Rodríguez-Franco; Matthew S Halquist; Dexian Ye; Shijun Zhang
Journal:  ACS Chem Neurosci       Date:  2014-05-22       Impact factor: 4.418

8.  Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release.

Authors:  YueMei Zhang; Bhagu R Bhavnani
Journal:  BMC Neurosci       Date:  2005-02-24       Impact factor: 3.288

9.  Synthesis and biological evaluation of aminonaphthols incorporated indole derivatives.

Authors:  Saundane Anand Raghunath; Kirankumar Nandibeoor Mathada
Journal:  Int J Med Chem       Date:  2014-09-10

10.  Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death.

Authors:  YueMei Zhang; XiaoFeng Lu; Bhagu R Bhavnani
Journal:  BMC Neurosci       Date:  2003-12-23       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.